cognisleep.com

What It Is

CogniSleep is an online CBT-I program — cognitive behavioral therapy for insomnia — designed for people with insomnia. It was created by Dr. Dacelin St. Martin, whose profile on the site describes triple board certification in sleep medicine, pediatrics, and internal medicine. The product is not positioned as a replacement for medical diagnosis or treatment, but rather as a supplemental tool for insomnia management after an initial assessment by a qualified healthcare professional, especially for patients referred by a physician.

Core Features and Product Format

Based on the available site content, CogniSleep centers on 6 course modules, each averaging about 10 minutes. The program helps users identify triggers for insomnia and build a plan to overcome it. It covers issues such as difficulty falling asleep, difficulty staying asleep, reliance on sleep aids, and daytime sleepiness. The website includes separate Patient and Provider/Physician entry points, plus login and registration, suggesting it may serve both patients and healthcare providers. However, it does not disclose details about any backend system, follow-up workflow, reporting, or institutional management features.

Pricing, Integrations, and Compliance

The site does not publicly list plans, pricing, free trials, or payment methods, nor does it state whether insurance, credit cards, or institutional purchasing are supported. From an enterprise software perspective, there is no visible information about third-party integrations, APIs, developer documentation, permission systems, or team collaboration. For healthcare products, privacy and compliance are usually important considerations, but this page only provides a medical disclaimer and does not disclose HIPAA status, data encryption, access controls, or data retention policies.

Pros, Cons, and Who It’s For

The main advantages are that it is based on CBT-I, non-drug, short-form, and easy to follow, with professional credibility from being physician-created. It also clearly states that it cannot treat sleep apnea, restless legs syndrome, narcolepsy, depression, or similar conditions, which helps define its boundaries. The downside is limited transparency around commercial terms, technical capabilities, and compliance, making it difficult to evaluate as an institution-grade SaaS purchase. It is best suited for patients who want to work with a doctor on behavioral intervention for insomnia, as well as sleep-medicine-related physicians who want to offer patients a supplemental tool.

Access from China and Alternatives

Accessibility from mainland China is unknown, and payment methods are not disclosed. For use by Chinese patients, English-language content, cross-border access, medical compliance, and payment issues would all need to be considered. Comparable options include Sleepio, Somryst, other digital CBT-I platforms, or CBT-I services provided by local hospital sleep centers.